Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings
Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development | HTML
Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
A human liver chimeric mouse model for non-alcoholic fatty liver disease - JHEP Reports
Biomedicines | Free Full-Text | Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis | HTML
Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes - Diabetes Research and Clinical Practice
Cureus | A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Frontiers | Hepatic Macrophage as a Key Player in Fatty Liver Disease
Livers | Free Full-Text | Oxidative Stress in Non-Alcoholic Fatty Liver Disease | HTML
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology & Metabolic Syndrome | Full Text
The diagnostic conundrum in non-alcoholic fatty liver disease
Frontiers | Gut Dysfunction and Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease publications and distribution of... | Download Scientific Diagram
Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis | Scientific Reports
Cureus | The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review
Nonalcoholic Fatty Liver Disease | North Carolina Medical Journal
Nonalcoholic Fatty Liver Disease: The Overlooked Complication of Type 2 Diabetes - Endotext - NCBI Bookshelf
Neutrophils in liver diseases: pathogenesis and therapeutic targets | Cellular & Molecular Immunology
New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis | SpringerLink
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation | Nature Communications
Frontiers | How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?
